BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND CDK4, PSK-J3, 1019, ENSG00000135446, MGC14458, CMM3, P11802 AND Staging
9 results:

  • 1. Effects of MFG-E8 expression on the biological characteristics of ovarian cancer cells via the AKT/mTOR/S6K signalling pathway.
    Li N; Wang Y; Liu L; Wang P; Wu X
    J Obstet Gynaecol; 2023 Dec; 43(1):2151354. PubMed ID: 36484512
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Locally advanced breast cancer.
    Aebi S; Karlsson P; Wapnir IL
    Breast; 2022 Mar; 62 Suppl 1(Suppl 1):S58-S62. PubMed ID: 34930650
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [18F]-Fluorodeoxyglucose Positron Emission Tomography/CT to Assess the Early Metabolic Response in Patients with Hormone Receptor-Positive HER2-Negative Metastasized breast cancer Treated with Cyclin-Dependent 4/6 Kinase Inhibitors.
    Seifert R; Küper A; Tewes M; Heuschmid M; Welt A; Fendler WP; Herrmann K; Decker T
    Oncol Res Treat; 2021; 44(7-8):400-407. PubMed ID: 34102639
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Accuracy and inter-reader agreement of breast MRI for cancer staging using 0.08 mmol/kg of gadobutrol.
    Cozzi A; Buragina G; Spinelli D; Schiaffino S; Zanardo M; Di Leo G; Carbonaro LA; Sardanelli F
    Clin Imaging; 2021 Apr; 72():154-161. PubMed ID: 33249403
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Tumor size and focality in breast carcinoma: Analysis of concordance between radiological imaging modalities and pathological examination at a cancer center.
    Di Pasquale Guadalupe L; De Jesús J; Xiong Y; Rosa M
    Ann Diagn Pathol; 2020 Oct; 48():151601. PubMed ID: 32871502
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [NEOADJUVANT TREATMENT OF LOCALLY ADVANCED ESTROGEN/PROGESTERONE POSITIVE, HER2NEU NEGATIVE breast cancer].
    Friedman NS; Shaham L; Sharon N; Barlev C
    Harefuah; 2020 May; 159(5):370-375. PubMed ID: 32431130
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. MiR-519d-3p suppresses breast cancer cell growth and motility via targeting LIM domain kinase 1.
    Li D; Song H; Wu T; Xie D; Hu J; Zhao J; Shen Q; Fang L
    Mol Cell Biochem; 2018 Jul; 444(1-2):169-178. PubMed ID: 29188531
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Lymph node counts and ratio in axillary dissections following neoadjuvant chemotherapy for breast cancer: a better alternative to traditional pN staging.
    Chen S; Liu Y; Huang L; Chen CM; Wu J; Shao ZM
    Ann Surg Oncol; 2014 Jan; 21(1):42-50. PubMed ID: 24013900
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Amplified CDK2 and cdc2 activities in primary colorectal carcinoma.
    Kim JH; Kang MJ; Park CU; Kwak HJ; Hwang Y; Koh GY
    Cancer; 1999 Feb; 85(3):546-53. PubMed ID: 10091728
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.